rosnilimab Shows Sustained Benefit in Rheumatoid Arthritis Thru 6 Months Jonathan Graf,MD Credit: University of California,San Francisco Rosnilimab continues to demonstrate a best-in-disease profile in patients with moderate-to-severe rheumatoid arthritis …
Tag:
rheumatology
-
-
Inpatient SUD Programs Show Promise for Infectious Disease Screening Kelly Dyer, MD Credit: Kelly Dyer on linkedin New research reveals teh benefits of integrating infectious disease (ID) screening into inpatient …
-
Maximizing Semaglutide’s Effectiveness: The Power of Combined Lifestyle Intervention Recent research highlights a meaningful synergy between medication and lifestyle changes for individuals managing overweight or obesity.A study analyzing data from …
-
Cardiovascular Advances: A Quarterly Review – Spring 2025 This past quarter witnessed important strides in cardiovascular medicine, marked by regulatory approvals, promising trial data, and insightful expert analysis. From groundbreaking …
-
Apremilast demonstrates Long-Term Benefit in Early Psoriatic Arthritis Affecting Weight-Bearing Joints Psoriatic arthritis (PsA) is a chronic inflammatory condition affecting an estimated 30% of individuals with psoriasis, translating to over …
-
The Unexpected Key to Fat Metabolism: How Limiting a Single Amino Acid Could Combat Obesity Recent research published in Nature Metabolism has revealed a surprising pathway for influencing fat metabolism, …
-
Semaglutide Shows Promise in Enhancing Mobility for Individuals with Peripheral Artery Disease and Type 2 Diabetes Table of Contents Semaglutide Shows Promise in Enhancing Mobility for Individuals with Peripheral Artery …
-
Optimizing Polyarticular Juvenile Idiopathic Arthritis (Poly-JIA) Management in Latin America: A Clinical Guide Table of Contents Optimizing Polyarticular Juvenile Idiopathic Arthritis (Poly-JIA) Management in Latin America: A Clinical Guide Polyarticular …
-
New research is providing clinicians with an overview of the role of immunosuppression therapy in non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (ILD).1 The data were presented at the American …
-
Promising New Treatment on the Horizon for night Vision Disturbances After Refractive Surgery Table of Contents Promising New Treatment on the Horizon for night Vision Disturbances After Refractive Surgery Understanding …